Yue Zhou

Mr. Yue Zhou


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Annals of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
HDHao Dong
Hao Dong
SWShiyan Wang
Shiyan Wang
CHChenji Hu
Chenji Hu
MWMao Wang
Mao Wang
TZTao Zhou
Tao Zhou
YZYue Zhou
Yue Zhou
Background: A major risk factor for neurodegenerative disorders is old age. Nutritional interventions that delay aging, such as calorie restriction (CR) and intermittent fasting (IF), as well as pharmaceuticals that affect the pathways linking nutrition and aging processes, have been developed in recent decades and have been shown to alleviate the effects of aging on the brain. Summary: CR is accomplished by alternating periods of ad libitum feeding and fasting. In animal models, IF has been shown to increase lifespan and slow the progression and severity of age-related pathologies such as cardiovascular and neurodegenerative diseases and cancer. According to recent research, dietary changes can help older people with dementia retain brain function. However, the mechanisms underlying the neuroprotective effect of IF on the aging brain and related questions in this area of study (i.e., the potential of IF to treat neurodegenerative disorders) remain to be examined. Key Messages: This review addresses the hypothesis that IF may have translational potential in protecting the aged brain while summarizing the research supporting the putative neuroprotective mechanisms of IF in animal models. Additionally, given the emerging understanding of the connection between aging and dementia, our investigations may offer a fresh perspective on the use of dietary interventions for enhancing brain function and preventing dementia in elderly individuals. Finally, the absence of guidelines regarding the application of IF in patients hampers its broad utilization in clinical practice, and further studies are needed to improve our knowledge of the long-term effects of IF on dementia before it can be widely prescribed. In conclusion, IF may be an ancillary intervention for preserving memory and cognition in elderly individuals.

19 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
LBLin Bai
Lin Bai
YZYue Zhou
Yue Zhou
JZJie Zhang
Jie Zhang
JMJunpeng Ma
Junpeng Ma
Type 2 diabetes mellitus (T2DM) shares a common molecular mechanism and underlying pathology with dementia, and studies indicate that dementia is widespread in people with T2DM. Currently, T2DM-induced cognitive impairment is characterized by altered insulin and cerebral glucose metabolism, leading to a shorter life span. Increasing evidence indicates that nutritional and metabolic treatments can possibly alleviate these issues, as there is a lack of efficient preventative and treatment methods. The ketogenic diet (KD) is a very high-fat, low-carbohydrate diet that induces ketosis in the body by producing a fasting-like effect, and neurons in the aged brain are protected from damage by ketone bodies. Moreover, the creation of ketone bodies may improve brain neuronal function, decrease inflammatory expression and reactive oxygen species (ROS) production, and restore neuronal metabolism. As a result, the KD has drawn attention as a potential treatment for neurological diseases, such as T2DM-induced dementia. This review aims to examine the role of the KD in the prevention of dementia risk in T2DM patients and to outline specific aspects of the neuroprotective effects of the KD, providing a rationale for the implementation of dietary interventions as a therapeutic strategy for T2DM-induced dementia in the future.

22 December 2023 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
TZTao Zhou
Tao Zhou
YZYuangao Zhong
Yuangao Zhong
YZYong Zhang
Yong Zhang
YZYue Zhou
Yue Zhou

6 July 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QCQianzhao Chen
Qianzhao Chen
HCHaoran Chi
Haoran Chi
SLShuang Liu
Shuang Liu
YZYue Zhou
Yue Zhou
The relationship between neuroimmune processes and drug addiction is currently unclear, although long-term drug use affects neuroimmune signalling. Currently, how neuroinflammation and neuroimmune signalling are linked to addiction is unclear. Therefore, the purpose of this review is to elucidate the roles of neuroimmune signalling, its interaction with neuroinflammation resulting from long-term drug use, and the possible influence of this interaction on the use of pharmacotherapeutic approaches for treating drug addiction. In this review, we address the roles of chemokines and cytokines in the rewarding and reinforcing effects of psychostimulants. Additionally, we provide an overview of novel anti-inflammatory therapeutic strategies that differ from conventional strategies by focusing on cytokines and chemokines. Understanding the role that neuroimmune signalling plays in drug addiction may help researchers develop innovative strategies for addressing this serious social problem.